About the Journal

Editorial board | For contributors | Publication and research ethics | Editorial policies

Aims and scope

Journal of Circulating Biomarkers (JCB) is an international, peer-reviewed, open access, scientific, online only journal, published continually. It focuses on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications, circulation protein and lipid markers, CTC, cfDNA and extracellular vesicle.

Journal of Circulating Biomarkers adopts a single anonymized peer-review process, which means that reviewer identity is not made visible to authors, author identity is visible to reviewers, reviewer and author identity are visible to the editors..Full details on the peer review process and editorial policies can be found here.

JCB publishes new articles as soon as they receive final approval from the authors and are assigned page numbers (online first, as customary now for scientific journals) and then collected in an issue, to guarantee rapid publication times and a timely content availability for its indexing databases. Authors retain the copyright of their article published in Journal of Circulating Biomarkers are free to reproduce and disseminate their work. Full details can be found here.

Articles published by JCB are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Full information on the open access policy can be found here.

All of this journal content is archived in Portico, which provides permanent archiving for electronic scholarly journals.